BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29764865)

  • 1. HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A.
    Alam H; Li N; Dhar SS; Wu SJ; Lv J; Chen K; Flores ER; Baseler L; Lee MG
    Cancer Res; 2018 Jul; 78(14):3834-3848. PubMed ID: 29764865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, expression, cellular localization, and molecular properties of a novel, alternative spliced HP1γ isoform, lacking the chromoshadow domain.
    Mathison A; Milech De Assuncao T; Dsouza NR; Williams M; Zimmermann MT; Urrutia R; Lomberk G
    PLoS One; 2020; 15(2):e0217452. PubMed ID: 32027651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation.
    Dhar SS; Brown C; Rizvi A; Reed L; Kotla S; Zod C; Abraham J; Abe JI; Rajaram V; Chen K; Lee M
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary exploration of SKA1 expression in lung adenocarcinoma and its clinical significance.
    Zeng W; Chen Y; Liu J; An Z; Yan H; Sun T
    Acta Biochim Biophys Sin (Shanghai); 2023 Dec; 55(12):2008-2012. PubMed ID: 37814813
    [No Abstract]   [Full Text] [Related]  

  • 5. MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes.
    Dhar SS; Zhao D; Lin T; Gu B; Pal K; Wu SJ; Alam H; Lv J; Yun K; Gopalakrishnan V; Flores ER; Northcott PA; Rajaram V; Li W; Shilatifard A; Sillitoe RV; Chen K; Lee MG
    Mol Cell; 2018 Jun; 70(5):825-841.e6. PubMed ID: 29861161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
    Alam H; Tang M; Maitituoheti M; Dhar SS; Kumar M; Han CY; Ambati CR; Amin SB; Gu B; Chen TY; Lin YH; Chen J; Muller FL; Putluri N; Flores ER; DeMayo FJ; Baseler L; Rai K; Lee MG
    Cancer Cell; 2020 Apr; 37(4):599-617.e7. PubMed ID: 32243837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
    Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
    Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of function of NCOR1 and NCOR2 impairs memory through a novel GABAergic hypothalamus-CA3 projection.
    Zhou W; He Y; Rehman AU; Kong Y; Hong S; Ding G; Yalamanchili HK; Wan YW; Paul B; Wang C; Gong Y; Zhou W; Liu H; Dean J; Scalais E; O'Driscoll M; Morton JEV; ; Hou X; Wu Q; Tong Q; Liu Z; Liu P; Xu Y; Sun Z
    Nat Neurosci; 2019 Feb; 22(2):205-217. PubMed ID: 30664766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
    Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
    Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea.
    Chondrou V; Stavrou EF; Markopoulos G; Kouraklis-Symeonidis A; Fotopoulos V; Symeonidis A; Vlachaki E; Chalkia P; Patrinos GP; Papachatzopoulou A; Sgourou A
    Hum Genomics; 2018 Oct; 12(1):45. PubMed ID: 30285874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
    Zhang L; Zhang Z; Yu Z
    J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
    Wu S; Wu D; Pan Y; Liu H; Shao Z; Wang M
    Pathol Res Pract; 2019 Feb; 215(2):292-301. PubMed ID: 30527357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
    Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
    BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARNT2 Tunes Activity-Dependent Gene Expression through NCoR2-Mediated Repression and NPAS4-Mediated Activation.
    Sharma N; Pollina EA; Nagy MA; Yap EL; DiBiase FA; Hrvatin S; Hu L; Lin C; Greenberg ME
    Neuron; 2019 Apr; 102(2):390-406.e9. PubMed ID: 30846309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway.
    He Z; Chen J; Chen X; Wang H; Tang L; Han C
    J Cell Physiol; 2021 Jan; 236(1):107-120. PubMed ID: 33459391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.
    Cai H; Yu Y; Ni X; Li C; Hu Y; Wang J; Chen F; Xi S; Chen Z
    Cell Death Dis; 2020 Dec; 11(12):1032. PubMed ID: 33268783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circ-NCOR2 accelerates papillary thyroid cancer progression by sponging miR-516a-5p to upregulate metastasis-associated protein 2 expression.
    Luan S; Fu P; Wang X; Gao Y; Shi K; Guo Y
    J Int Med Res; 2020 Sep; 48(9):300060520934659. PubMed ID: 32940102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HP1γ Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3.
    Yi SA; Kim GW; Yoo J; Han JW; Kwon SH
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation.
    Gong L; Hu Y; He D; Zhu Y; Xiang L; Xiao M; Bao Y; Liu X; Zeng Q; Liu J; Zhou M; Zhou Y; Cheng Y; Zhang Y; Deng L; Zhu R; Lan H; Cao K
    Cancer Cell Int; 2020; 20():194. PubMed ID: 32508530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.